FMFakai Mi

Fakai Mi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fakai Mi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Fang Wang

    State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China

    1 shared publication
  • Haiyu Feng

    State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China

    1 shared publication
  • Huanhuan Fu

    Shaanxi University of Chinese Medicine

    1 shared publication
  • Li Wang

    State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China

    1 shared publication
  • Yaomin Wang

    State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China

    1 shared publication
  • Ye Yang

    State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Shaanxi Provincial Collaborative Innovation Center for the Industrialization of Traditional Chinese Medicine Resources, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, P.R. China

    1 shared publication

Latest Publications

  • The Metabolites of Secoiridoid Enantiomers and Diastereomers with 9-Carbon Skeleton in Gentiana macrophylla Pall

    by Yaomin Wang, Ye Yang, Huanhuan Fu, Fakai Mi, Fang Wang, Li Wang, Haiyu Feng, Zhenggang Yue, Yihan He

    Introduction: The secoiridoid metabolites with a 10-carbon skeleton, such as gentiopicroside, swertiamarin, and sweroside, were identified as the main components in Gentiana macrophylla. However, various unpredictable rearrangement metabolites might be generated due to the high reactivity of the hem-iacetal in their structures. Thus, our ongoing research aimed to explore additional metabolites with new carbon skeleton features from G. macrophylla. Methods: Metabolites were separated and purified using multi-chromatographic techniques, such as silica gel, HP-20 resin gel, LH-20 dextran gel, C18 gel, and chiral CHIRALPAK AD-H column chromatog-raphy; and characterized by multi-spectroscopic methods, including NMR and X-ray spectroscopy, ex-perimental CD measurement compared with ECD calculation, and carbon NMR calculation. Moreover, their biosynthetic pathways were deduced according to the KEGG pathway and their correlations with normal secoiridoid metabolites in G. macrophylla. Results: A pair of norsecoiridoid diastereomers, (3R, 6R, 8S)-3-methoxy-6-hydroxy-swerimuslactone A (1) and (3S, 6R, 8R)-3-methoxy-6-hydroxy-swerimuslactone A (2), were isolated and identified from G. macrophylla, along with two pairs of racemates (3) and (4) with [α]²⁰_D = 0. These racemates were further separated by chiral column chromatography into two pairs of norsecoiridoid enantiomers: (-)-(5S, 8S)-gentimaclactone A (3a) and (+)-(5R, 8R)-gentimaclactone A (3b), and (+)-(3S, 8R)-swerimilegenin E (4a) and (-)-(3R, 8S)-swerimilegenin E (4b), respectively. Discussion: All compounds were determined to have a 9-carbon skeleton, derived from the normal 10-carbon secoiridoids in G. macrophylla. Their biosynthetic pathways were deduced to occur via ring-open-ing of the hemiacetal at C-1, ring-closing with the hydroxyl group at C-8, followed by degradation of a CHO group. Conclusion: Four norsecoiridoids with a 9-carbon skeleton, derived from the normal 10-carbon secoir-idoids, were isolated from G. macrophylla. They were present as pairs of diastereomers or racemates, which were further separated into pairs of enantiomers. Among them, the diastereomer pair (3R, 6R, 8S)-3-methoxy-6-hydroxy-swerimuslactone A (1) and (3S, 6R, 8R)-3-methoxy-6-hydroxy-swerimuslactone A (2), and the enantiomer pair (-)-(5S, 8S)-gentimaclactone A (3a) and (+)-(5R, 8R)-gentimaclactone A (3b) were identified as new compounds. Additionally, the plausible biosynthetic pathways of these com-pounds were proposed for future studies.